References
- Cannata-AndiaJBFernandez-MartinJLThe clinical impact of aluminium overload in renal failureNephrol Dial Transplant200217Suppl 291211904351
- RobPMNiederstadtCReuscheEDementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and managementCNS Drugs20011569169911580308
- MallucheHHAluminium and bone disease in chronic renal failureNephrol Dial Transplant200217Suppl 2212411904354
- AgarwalAKPractical approach to the diagnosis and treatment of anemia associated with CKD in elderlyJ Am Med Dir Assoc20067S7S12 quiz S7–S2117098634
- JaffeJALiftmanCGlickmanJDFrequency of elevated serum aluminum levels in adult dialysis patientsAm J Kidney Dis20054631631916112051
- National Kidney FoundationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseAm J Kidney Dis200342S1S20114520607
- ChazanJALewNLLowrieEGIncreased serum aluminum. An independent risk factor for mortality in patients undergoing long-term hemodialysisArch Intern Med19911513193221992959
- SalahudeenAKDeogaygayBFleischmannEBowerJDRace-dependent survival disparity on hemodialysis: higher serum aluminum as an independent risk factor for higher mortality in whitesAm J Kidney Dis2000361147115411096039
- GaultPMAllenKRNewtonKEPlasma aluminium: a redundant test for patients on dialysis?Ann Clin Biochem200542515415802033
- DaugirdasJTDepnerTAGreeneTLevinNWChertowGMRoccoMVStandard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearanceKidney Int20107763764420107428
- HuangWHHsuCWWengCHYenTHLinJHLeeMAssociation of a high normalized protein catabolic rate and low serum albumin level with carpal tunnel syndrome in hemodialysis patientsMedicine201695e405027368039
- AzikFMEkimMSakalliogluOAydinAA different interaction between parathyroid hormone, calcitriol and serum aluminum in chronic kidney disease; a pilot studyInt Urol Nephrol20114346747020535635
- BerlandYCharbitMHenryJFTogaMCanoJPOlmerMAluminium overload of parathyroid glands in haemodialysed patients with hyperparathyroidism: effect on bone remodellingNephrol Dial Transplant198834174223140127
- MurakamiKYoshinoMAluminum decreases the glutathione regeneration by the inhibition of NADP-isocitrate dehydrogenase in mitochondriaJ Cell Biochem2004931267127115486972
- MorenaMDelboscSDupuyAMCanaudBCristolJPOverproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammationHemodial Int20059374616191052
- StenvinkelPThe role of inflammation in the anaemia of end-stage renal diseaseNephrol Dial Transplant200116Suppl 7364011590255
- LukiwWJPercyMEKruckTPNanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary cultureJ Inorg Biochem2005991895189815961160
- GuoCHChenPCHsiaSHsuGSLiuPJThe relationship of plasma aluminum to oxidant-antioxidant and inflammation status in asthma patientsEnviron Toxicol Pharmacol201335303823228705
- Kalantar-ZadehKIkizlerTABlockGAvramMMKoppleJDMalnutrition-inflammation complex syndrome in dialysis patients: causes and consequencesAm J Kidney Dis20034286488114582032
- KrewskiDYokelRANieboerEHuman health risk assessment for aluminium, aluminium oxide, and aluminium hydroxideJ Toxicol Environ Health B Crit Rev200710Suppl 1126918085482
- JadejaYPKherVProtein energy wasting in chronic kidney disease: an update with focus on nutritional interventions to improve outcomesIndian J Endocrinol Metab20121624625122470862
- SoniMGWhiteSMFlammWGBurdockGASafety evaluation of dietary aluminumRegul Toxicol Pharmacol200133667911259180
- BohrerDBertagnolliDCde OliveiraSMRole of medication in the level of aluminium in the blood of chronic haemodialysis patientsNephrol Dial Transplant2009241277128119028749